President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Trump wanted to advance the ‘most favored nation’ policy in his first term but faced resistance from industry and the courts.

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big ...

President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the ...

The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered ...